Association of Apixaban Therapy and Prothrombin Time in Patients With Atrial Fibrillation–Single Center Cohort Study–
M Kanemoto, H Kuhara, T Ueda, T Shinohara… - Circulation …, 2014 - jstage.jst.go.jp
… Background: This study evaluated whether measuring prothrombin time (PT) using …
apixaban-associated anticoagulant activity in Japanese patients with non-valvular atrial fibrillation (…
apixaban-associated anticoagulant activity in Japanese patients with non-valvular atrial fibrillation (…
Association of Apixaban Therapy and Prothrombin Time in Patients With Atrial Fibrillation: Single Center Cohort Study
K Masashi, K Hiroko, U Toru, S Takahiro, O Takamasa… - 日本循環器學誌, 2014 - cir.nii.ac.jp
… Background:This study evaluated whether measuring prothrombin time (PT) using …
apixaban-associated anticoagulant activity in Japanese patients with non-valvular atrial fibrillation (…
apixaban-associated anticoagulant activity in Japanese patients with non-valvular atrial fibrillation (…
[HTML][HTML] Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation
A Mavri, N Vene, M Božič-Mijovski, M Miklič… - Scientific Reports, 2021 - nature.com
… over time and the association of trough and peak apixaban … of anticoagulant treatment for
each patient with atrial fibrillation. The … partial thromboplastin time (APTT) (Pathromtin SL) and …
each patient with atrial fibrillation. The … partial thromboplastin time (APTT) (Pathromtin SL) and …
[HTML][HTML] Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients
L Onelöv, M Božič-Mijovski, A Mavri - Scientific Reports, 2024 - nature.com
… Apixaban at trough and peak, and to evaluate association between PT DOAC expressed in
Clot Time Ratio CTR and clinical outcomes in patients with atrial … run prothrombin time assays…
Clot Time Ratio CTR and clinical outcomes in patients with atrial … run prothrombin time assays…
Factors that determine the prothrombin time in patients with atrial fibrillation receiving rivaroxaban
JH Huang, YK Lin, CC Chung… - Clinical and Applied …, 2018 - journals.sagepub.com
… However, the Canadian Cardiovascular Society suggests follow-up for reassessment of
therapy at least every 6 months and every 3∼6 months for renal impairment in patients receiving …
therapy at least every 6 months and every 3∼6 months for renal impairment in patients receiving …
Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation
M Skeppholm, F Al-Aieshy, M Berndtsson… - Thrombosis research, 2015 - Elsevier
… treatment requires frequent monitoring of the international normalized ratio of prothrombin
time (… possible reasons for the lack of association between age and apixaban concentration. …
time (… possible reasons for the lack of association between age and apixaban concentration. …
Direct oral anticoagulants plasma levels in patients with atrial fibrillation at the time of bleeding: a pilot prospective study
I Škorňová, M Samoš, T Bolek… - Journal of …, 2021 - journals.lww.com
… observations) favor an association between high rivaroxaban … will be needed for a final
confirmation of this association. … K Antagonist Treatment) trial enrolling apixaban-treated patients …
confirmation of this association. … K Antagonist Treatment) trial enrolling apixaban-treated patients …
Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry
S Helmert, S Marten, H Mizera, A Reitter… - Journal of Thrombosis …, 2017 - Springer
… for decades [1] but they require regular measurement of prothrombin time or international …
of major bleeding according to the International Society on Thrombosis and Haemostasis (ISTH…
of major bleeding according to the International Society on Thrombosis and Haemostasis (ISTH…
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
C Christersson, L Wallentin, U Andersson… - Heart, 2019 - heart.bmj.com
… without substantial association with lower risk of stroke/SE.18 Elevated F1+2 levels have
been described in stroke patients with AF, and as F1+2 levels reflect thrombin generation they …
been described in stroke patients with AF, and as F1+2 levels reflect thrombin generation they …
Association between prothrombin time and bleeding in hospitalized patients receiving rivaroxaban
AE Woodruff, MM Wovkulich, BT Mogle… - American Journal of …, 2018 - academic.oup.com
… PT was measured in a major clinical trial of rivaroxaban versus warfarin for treatment of
nonvalvular atrial fibrillation (the ROCKET AF trial), 15 and the values were used by FDA to …
nonvalvular atrial fibrillation (the ROCKET AF trial), 15 and the values were used by FDA to …